Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,281.94
(
0.11%
)
News Focus
News Focus

Replies to post #191 on Cardiol Therapeutics Inc (CRDL)

Replies to #191 on Cardiol Therapeutics Inc (CRDL)
icon url

MahinAgency

11/06/24 10:59 AM

#214 RE: williams45 #191

NASDAQ: CRDL is advancing CardiolRx™ for acute myocarditis and recurrent pericarditis, both in Phase II trials. The company raised $13.5 million
icon url

MahinAgency

11/14/24 2:48 PM

#234 RE: williams45 #191

NASDAQ: $CRDL lets See Red To Green, 

H.C. Wainwright maintains a "Buy" rating for Cardiol Therapeutics with a price target of $9.00.

The company recently raised $13.5 million
Bullish
Bullish
icon url

MahinAgency

11/15/24 2:31 PM

#237 RE: williams45 #191

NASDAQ: $CRDL SHORT SQUEEZE ALERTS, STAY TUNED

Addressing urgent unmet medical needs: CardiolRx™ targets acute myocarditis, a life-threatening condition with no FDA-approved treatments
Bullish
Bullish